Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.

Autor: Ayhan A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Başkent University, Ankara, Turkey., Topfedaisi Ozkan N; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Öz M; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey. ozmurat@gmail.com., Kimyon Comert G; Department of Gynecologic Oncology, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Firat Cuylan Z; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Çoban G; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Başkent University, Ankara, Turkey., Turkmen O; Department of Gynecologic Oncology, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Erdem B; Department of Gynecologic Oncology, Kanuni Sultan Suleyman Teaching and Research Hospital, Faculty of Medicine, University of Health Sciences, Istanbul, Turkey., Şahin H; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Akbayır Ö; Department of Gynecologic Oncology, Kanuni Sultan Suleyman Teaching and Research Hospital, Faculty of Medicine, University of Health Sciences, Istanbul, Turkey., Dede M; Department of Obstetrics and Gynecology, Gulhane Training and Researh Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Turan AT; Department of Gynecologic Oncology, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Celik H; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Başkent University, Ankara, Turkey., Güngör T; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey., Haberal A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Başkent University, Ankara, Turkey., Arvas M; Division of Gynecologic Oncology, Department of Gynecologic Oncology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey., Meydanli MM; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey.

Publikováno v: Journal of gynecologic oncology [J Gynecol Oncol] 2018 Jul; Vol. 29 (4), pp. e48. Date of Electronic Publication: 2018 Mar 13.